CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab)For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01884740
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:02.208976+00:00
Published At: 2022-08-09T00:00:00+00:00
Record Updated At: 2022-08-09
Results Posted At: 2022-08-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glioblastoma Multiforme", "Fibrillary Astrocytoma of Brain", "Glioma of Brainstem", "Anaplastic Astrocytoma", "Pilomyxoid Astrocytoma", "Mixed Oligodendroglioma-Astrocytoma", "Brain Stem Glioma", "Diffuse Intrinsic Pontine Glioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-08-09"
protocolSection.identificationModule.nctId: "NCT01884740"
protocolSection.identificationModule.officialTitle: "Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab)For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-08-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.